18.06.2021 | Research Communication
Survival Outcomes for Colorectal Cancer with Isolated Liver Metastases at Academic Versus Community Hospitals
Vanessa M. Welten, Adam C. Fields, James Yoo, Jennifer L. Irani, Joel E. Goldberg, Ronald Bleday, Nelya Melnitchouk
Journal of Gastrointestinal Surgery
Einloggen, um Zugang zu erhalten
Colorectal cancer is the third leading cause of cancer-related deaths in the USA. Twenty to twenty-five percent of patients with colorectal cancer present with metastatic disease at diagnosis, with liver being the most common site of distant metastasis.
Survival has greatly improved over time with the introduction of metastasectomy, with 5-year survival rates ranging from 38 to as high as 58%.
Hepatic resection is now the treatment of choice for isolated resectable colorectal liver metastases.
We aim to compare outcomes for patients with stage IV colon and rectal cancer with isolated liver metastases treated at academic versus community hospitals. …